Published in Am J Cardiol on February 27, 1984
Twenty-five years in the making: flecainide is safe and effective for the management of atrial fibrillation. Europace (2010) 1.43
Which patient should be referred to an electrophysiologist: supraventricular tachycardia. Heart (2002) 0.81
Field and action potential recordings in heart slices: correlation with established in vitro and in vivo models. Br J Pharmacol (2012) 0.80
Narrow therapeutic index drugs: a clinical pharmacological consideration to flecainide. Eur J Clin Pharmacol (2015) 0.76
Flecainide plasma concentrations correlated to inhibition of a bundle of Kent. Br J Clin Pharmacol (1987) 0.75
An experimental model of sudden death due to low-energy chest-wall impact (commotio cordis) N Engl J Med (1998) 4.92
Quality of life and clinical outcomes in elderly patients treated with ventricular pacing as compared with dual-chamber pacing. Pacemaker Selection in the Elderly Investigators. N Engl J Med (1998) 4.22
Efficacy of implantable cardioverter-defibrillators for the prevention of sudden death in patients with hypertrophic cardiomyopathy. N Engl J Med (2000) 4.04
Electrical alternans and vulnerability to ventricular arrhythmias. N Engl J Med (1994) 4.00
Fish consumption and risk of sudden cardiac death. JAMA (1998) 3.06
Influence of the implantable cardioverter/defibrillator on sudden death and total mortality in patients evaluated for cardiac transplantation. Circulation (1995) 2.97
Diagnosing syncope. Part 2: Unexplained syncope. Clinical Efficacy Assessment Project of the American College of Physicians. Ann Intern Med (1997) 2.96
Proteins of the human erythrocyte membrane as modified by pronase. J Mol Biol (1971) 2.51
Adverse reactions during treatment with amiodarone hydrochloride. Br Med J (Clin Res Ed) (1983) 2.43
Diagnosing syncope. Part 1: Value of history, physical examination, and electrocardiography. Clinical Efficacy Assessment Project of the American College of Physicians. Ann Intern Med (1997) 2.36
The QT interval. Prog Cardiovasc Dis (2001) 2.22
Influence of implantable cardioverter-defibrillators on the long-term prognosis of survivors of out-of-hospital cardiac arrest. Circulation (1993) 2.20
Acute cardiac events temporally related to cocaine abuse. N Engl J Med (1986) 2.18
Subclavian crush syndrome complicating transvenous cardioverter defibrillator systems. Pacing Clin Electrophysiol (1995) 2.14
Improving survival from sudden cardiac arrest: the role of the automated external defibrillator. JAMA (2001) 2.03
Syncope: current diagnostic evaluation and management. Ann Intern Med (1990) 1.92
A comparison of T-wave alternans, signal averaged electrocardiography and programmed ventricular stimulation for arrhythmia risk stratification. J Am Coll Cardiol (2000) 1.89
Electrical alternans and cardiac electrical instability. Circulation (1988) 1.86
Surgical coronary revascularization in survivors of prehospital cardiac arrest: its effect on inducible ventricular arrhythmias and long-term survival. J Am Coll Cardiol (1990) 1.73
An occidental case of cardiomyopathy and selenium deficiency. N Engl J Med (1981) 1.69
Out-of-hospital cardiac arrest. Use of electrophysiologic testing in the prediction of long-term outcome. N Engl J Med (1988) 1.68
Sex differences in cardiac arrest survivors. Circulation (1996) 1.57
Localization of the sites of conduction abnormalities in a mouse model of myotonic dystrophy. J Cardiovasc Electrophysiol (1999) 1.53
Sudden death in young athletes. N Engl J Med (1995) 1.50
Sudden cardiac death: management of high-risk patients. Ann Intern Med (1991) 1.49
Mutations in the long QT gene, KCNQ1, are an uncommon cause of atrial fibrillation. Heart (2004) 1.45
Use of correlation waveform analysis in discrimination between anterograde and retrograde atrial electrograms during ventricular tachycardia. J Cardiovasc Electrophysiol (2001) 1.39
Immediate reproducibility of electrically induced sustained monomorphic ventricular tachycardia before and during antiarrhythmic therapy. J Am Coll Cardiol (1991) 1.39
Evolving strategies for the management of atrial fibrillation. The role of amiodarone. JAMA (1992) 1.37
Out-of-hospital cardiac arrest: electrophysiologic observations and selection of long-term antiarrhythmic therapy. N Engl J Med (1980) 1.36
Selective activation of the K(+)(ATP) channel is a mechanism by which sudden death is produced by low-energy chest-wall impact (Commotio cordis). Circulation (1999) 1.35
Arrhythmogenic right ventricular dysplasia: clinical results with implantable cardioverter defibrillators. J Interv Card Electrophysiol (1997) 1.33
Amiodarone keratopathy: drug-induced lipid storage disease. Arch Ophthalmol (1981) 1.26
An analysis of the cost effectiveness of the implantable defibrillator. Circulation (1990) 1.26
Implantation of transvenous nonthoracotomy cardioverter-defibrillator systems in patients with permanent endocardial pacemakers. Am Heart J (1995) 1.22
Comparison of frequency of complications of implantable cardioverter-defibrillators in children versus adults. Am J Cardiol (1999) 1.20
Mechanisms of death in the CABG Patch trial: a randomized trial of implantable cardiac defibrillator prophylaxis in patients at high risk of death after coronary artery bypass graft surgery. Circulation (1999) 1.19
Radiofrequency ablation of slow pathway in patients with atrioventricular nodal reentrant tachycardia. Do arrhythmia recurrences correlate with persistent slow pathway conduction or site of successful ablation? Circulation (1994) 1.17
Complications of dual chamber pacemaker implantation in the elderly. Pacemaker Selection in the Elderly (PASE) Investigators. J Interv Card Electrophysiol (1998) 1.17
A comparative analysis of antegrade and retrograde conduction patterns in man. Circulation (1975) 1.16
The automatic implantable cardioverter-defibrillator: efficacy, complications and survival in patients with malignant ventricular arrhythmias. J Am Coll Cardiol (1988) 1.16
Connexin40-deficient mice exhibit atrioventricular nodal and infra-Hisian conduction abnormalities. J Cardiovasc Electrophysiol (2000) 1.14
Precipitation of cardiac arrest by verapamil in patients with Wolff-Parkinson-White syndrome. Ann Intern Med (1986) 1.11
Impact directly over the cardiac silhouette is necessary to produce ventricular fibrillation in an experimental model of commotio cordis. J Am Coll Cardiol (2001) 1.11
Antiarrhythmic drugs: a possible cause of out-of-hospital cardiac arrest. N Engl J Med (1983) 1.11
Primary pulmonary hypertension treated with oral phentolamine. Ann Intern Med (1979) 1.10
Treatment of ventricular tachycardia by transcatheter radiofrequency ablation in patients with ischemic heart disease. Circulation (1994) 1.09
The cardiac arrhythmia suppression trial (CAST). N Engl J Med (1989) 1.09
Long-term infection rates associated with the pectoral versus abdominal approach to cardioverter- defibrillator implants. Am J Cardiol (2001) 1.08
Demonstration of re-entry within the His-Purkinje system in man. Circulation (1974) 1.08
The central nervous system as a site of action for the coronary vasoconstrictor effect of digoxin. J Clin Invest (1974) 1.07
Intracardiac electrophysiologic techniques in recurrent syncope of unknown case. Ann Intern Med (1981) 1.07
Asystole after exercise in healthy persons. Ann Intern Med (1994) 1.07
A teenager with pacemaker twiddler syndrome. J Pediatr (1997) 1.05
Electrophysiologic response to moricizine in patients with sustained ventricular arrhythmias. Ann Intern Med (1992) 1.05
Prevalence and prognostic significance of atrial arrhythmias after orthotopic cardiac transplantation. J Am Coll Cardiol (1995) 1.05
Analysis of intracardiac electrograms showing monomorphic ventricular tachycardia in patients with implantable cardioverter-defibrillators. Am J Cardiol (2000) 1.04
Radiofrequency catheter ablation for cardiac tachyarrhythmias. Ann Intern Med (1994) 1.03
Low yield of rule-out myocardial infarction protocol in patients presenting with syncope. Am J Cardiol (2001) 1.03
Adenosine and the treatment of supraventricular tachycardia. Am J Med (1992) 1.03
Long-term clinical outcome of ventricular tachycardia or fibrillation treated with amiodarone. Am J Cardiol (1984) 1.02
Repolarization inhomogeneities in ventricular myocardium change dynamically with abrupt cycle length shortening. Circulation (1991) 1.01
The neurogenic vasoconstrictor effect of digitalis on coronary vascular resistance. J Clin Invest (1974) 1.01
Postexercise peril. Plasma catecholamines and exercise. JAMA (1984) 1.01
A consensus report on antiarrhythmic drug use. Clin Cardiol (1994) 1.01
The clinical course of palpitations in medical outpatients. Arch Intern Med (1995) 1.01
Clinical profile of commotio cordis: an under appreciated cause of sudden death in the young during sports and other activities. J Cardiovasc Electrophysiol (1999) 1.00
Analysis of the initiation of spontaneous monomorphic ventricular tachycardia by stored intracardiac electrograms. J Am Coll Cardiol (1994) 1.00
Antegrade and retrograde conduction characteristics in three patterns of paroxysmal atrioventricular junctional reentrant tachycardia. Am Heart J (1978) 0.99
Transvenous cardioverter-defibrillator implantation via persistent left superior vena cava. Am Heart J (1995) 0.98
Consensus statement on indications, guidelines for use, and recommendations for follow-up of implantable cardioverter defibrillators. North American Society of Electrophysiology and Pacing. Pacing Clin Electrophysiol (2001) 0.96
Pseudo-pacemaker syndrome following inadvertent fast pathway ablation for atrioventricular nodal reentrant tachycardia. J Cardiovasc Electrophysiol (1993) 0.94
Cardiovascular causes of loss of consciousness in patients with presumed epilepsy: a cause of the increased sudden death rate in people with epilepsy? Am J Med (1994) 0.94
Psychiatric disorders in medical outpatients complaining of palpitations. J Gen Intern Med (1994) 0.92
Commotio cordis: cardiovascular manifestations of a rare survivor. Chest (1998) 0.91
Idiopathic ventricular fibrillation: is there a role for electrophysiologic-guided antiarrhythmic drug therapy? J Cardiovasc Electrophysiol (1999) 0.91
Endocardial, intramural, and epicardial activation patterns during sustained monomorphic ventricular tachycardia in late canine myocardial infarction. Circ Res (1987) 0.91
Junctional tachycardias: anatomic substrate and its significance in ablative procedures. J Am Coll Cardiol (1991) 0.91
Mycobacterium bovis infection of an implantable defibrillator following intravesical therapy with bacille Calmette-Guérin. Clin Infect Dis (1993) 0.91